Baxter International Inc. (0QK8.L)
USD 29.53
(-0.37%)
USD 29.53
(-0.37%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.77 Billion USD | 105.04% |
| 2022 | -849 Million USD | -48.83% |
| 2021 | 2.51 Billion USD | 17.04% |
| 2020 | 2.53 Billion USD | -19.21% |
| 2019 | 1.87 Billion USD | 1.55% |
| 2018 | 2.47 Billion USD | -14.93% |
| 2017 | 2.05 Billion USD | -59.3% |
| 2016 | 1.97 Billion USD | 806.14% |
| 2015 | 1.49 Billion USD | -84.56% |
| 2014 | 1.63 Billion USD | 2.54% |
| 2013 | 3.48 Billion USD | -5.1% |
| 2012 | 3.69 Billion USD | 25.19% |
| 2011 | 3.63 Billion USD | 4.43% |
| 2010 | 2.76 Billion USD | -17.64% |
| 2009 | 3.4 Billion USD | 35.54% |
| 2008 | 3.23 Billion USD | -12.68% |
| 2007 | 2.81 Billion USD | 17.93% |
| 2006 | 2.41 Billion USD | 18.09% |
| 2005 | 2.19 Billion USD | -12.32% |
| 2004 | 1.15 Billion USD | -6.69% |
| 2003 | 2.14 Billion USD | 4.53% |
| 2002 | 2.15 Billion USD | 1.5% |
| 2001 | 1.93 Billion USD | 25.8% |
| 2000 | 1.71 Billion USD | 26.61% |
| 1999 | 1.52 Billion USD | -23.08% |
| 1998 | 1.35 Billion USD | 13.47% |
| 1997 | 1.2 Billion USD | 42.67% |
| 1996 | 1.25 Billion USD | -4.21% |
| 1995 | 1.15 Billion USD | -20.05% |
| 1994 | 1.54 Billion USD | 45.93% |
| 1993 | 733 Million USD | -31.34% |
| 1992 | 1.49 Billion USD | -0.19% |
| 1991 | 1.51 Billion USD | 103.36% |
| 1990 | 745 Million USD | -38.02% |
| 1989 | 1.2 Billion USD | 11.3% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 634 Million USD | -80.89% |
| 2024 Q1 | 667 Million USD | -12.23% |
| 2023 Q2 | 302 Million USD | 61.5% |
| 2023 Q4 | 729 Million USD | 1756.82% |
| 2023 Q3 | -44 Million USD | -114.57% |
| 2023 Q1 | 187 Million USD | -49.18% |
| 2023 FY | - USD | 105.04% |
| 2022 Q1 | 534 Million USD | 49.58% |
| 2022 Q2 | 720 Million USD | 34.83% |
| 2022 Q4 | 368 Million USD | 38.87% |
| 2022 FY | - USD | -48.83% |
| 2022 Q3 | 265 Million USD | -63.19% |
| 2021 Q4 | 357 Million USD | -50.42% |
| 2021 Q3 | 720 Million USD | 10.77% |
| 2021 Q2 | 650 Million USD | 7.97% |
| 2021 FY | - USD | 17.04% |
| 2021 Q1 | 602 Million USD | 142.74% |
| 2020 Q3 | 690 Million USD | 27.54% |
| 2020 Q4 | 248 Million USD | -64.06% |
| 2020 FY | - USD | -19.21% |
| 2020 Q2 | 541 Million USD | -12.46% |
| 2020 Q1 | 618 Million USD | 1288.46% |
| 2019 Q3 | 682 Million USD | 78.07% |
| 2019 Q4 | -52 Million USD | -107.62% |
| 2019 Q2 | 383 Million USD | -6.36% |
| 2019 Q1 | 409 Million USD | -10.31% |
| 2019 FY | - USD | 1.55% |
| 2018 Q3 | 417 Million USD | 0.48% |
| 2018 FY | - USD | -14.93% |
| 2018 Q4 | 456 Million USD | 9.35% |
| 2018 Q2 | 415 Million USD | 12.16% |
| 2018 Q1 | 370 Million USD | 20.52% |
| 2017 Q2 | 319 Million USD | -6.73% |
| 2017 Q3 | 304 Million USD | -4.7% |
| 2017 FY | - USD | -59.3% |
| 2017 Q4 | 307 Million USD | 0.99% |
| 2017 Q1 | 342 Million USD | -28.9% |
| 2016 Q4 | 481 Million USD | 238.73% |
| 2016 FY | - USD | 806.14% |
| 2016 Q1 | 3.35 Billion USD | 1316.46% |
| 2016 Q2 | 1.22 Billion USD | -63.39% |
| 2016 Q3 | 142 Million USD | -88.45% |
| 2015 Q3 | 1 Million USD | -99.8% |
| 2015 FY | - USD | -84.56% |
| 2015 Q1 | 560 Million USD | -36.72% |
| 2015 Q2 | 502 Million USD | -10.36% |
| 2015 Q4 | 237 Million USD | 23600.0% |
| 2014 Q3 | 875 Million USD | -8.47% |
| 2014 FY | - USD | 2.54% |
| 2014 Q1 | 988 Million USD | 36.84% |
| 2014 Q4 | 885 Million USD | 1.14% |
| 2014 Q2 | 956 Million USD | -3.24% |
| 2013 Q4 | 722 Million USD | -22.7% |
| 2013 FY | - USD | -5.1% |
| 2013 Q1 | 901 Million USD | 16.41% |
| 2013 Q2 | 943 Million USD | 4.66% |
| 2013 Q3 | 934 Million USD | -0.95% |
| 2012 FY | - USD | 25.19% |
| 2012 Q1 | 811 Million USD | 29.76% |
| 2012 Q2 | 715 Million USD | -11.84% |
| 2012 Q3 | 763 Million USD | 6.71% |
| 2012 Q4 | 774 Million USD | 1.44% |
| 2011 FY | - USD | 4.43% |
| 2011 Q1 | 745 Million USD | 4.93% |
| 2011 Q2 | 831 Million USD | 11.54% |
| 2011 Q3 | 745 Million USD | -10.35% |
| 2011 Q4 | 625 Million USD | -16.11% |
| 2010 Q2 | 698 Million USD | -3.19% |
| 2010 Q4 | 710 Million USD | -8.62% |
| 2010 Q1 | 721 Million USD | -20.94% |
| 2010 FY | - USD | -17.64% |
| 2010 Q3 | 777 Million USD | 11.32% |
| 2009 FY | - USD | 35.54% |
| 2009 Q3 | 732 Million USD | -2.14% |
| 2009 Q2 | 748 Million USD | 12.82% |
| 2009 Q1 | 663 Million USD | -23.17% |
| 2009 Q4 | 912 Million USD | 24.59% |
| 2008 FY | - USD | -12.68% |
| 2008 Q2 | 867 Million USD | 22.98% |
| 2008 Q4 | 863 Million USD | 6.94% |
| 2008 Q3 | 807 Million USD | -6.92% |
| 2008 Q1 | 705 Million USD | -4.73% |
| 2007 FY | - USD | 17.93% |
| 2007 Q4 | 740 Million USD | 10.12% |
| 2007 Q3 | 672 Million USD | -18.84% |
| 2007 Q2 | 828 Million USD | 26.61% |
| 2007 Q1 | 654 Million USD | 0.77% |
| 2006 Q2 | 592 Million USD | 9.02% |
| 2006 Q1 | 543 Million USD | 25.69% |
| 2006 FY | - USD | 18.09% |
| 2006 Q4 | 649 Million USD | -3.13% |
| 2006 Q3 | 670 Million USD | 13.18% |
| 2005 Q3 | 536 Million USD | -8.53% |
| 2005 FY | - USD | -12.32% |
| 2005 Q2 | 586 Million USD | 23.11% |
| 2005 Q1 | 476 Million USD | 31.49% |
| 2005 Q4 | 432 Million USD | -19.4% |
| 2004 Q3 | 538 Million USD | -46.73% |
| 2004 Q1 | 460 Million USD | -30.3% |
| 2004 Q4 | 362 Million USD | -32.71% |
| 2004 FY | - USD | -6.69% |
| 2004 Q2 | 1.01 Billion USD | 119.57% |
| 2003 Q2 | 497 Million USD | 75.46% |
| 2003 Q4 | 664 Million USD | 21.32% |
| 2003 Q3 | 537 Million USD | -36.08% |
| 2003 Q1 | 459 Million USD | -34.81% |
| 2003 FY | - USD | 4.53% |
| 2002 Q1 | 475 Million USD | -52.06% |
| 2002 Q4 | 618 Million USD | 31.68% |
| 2002 Q2 | 517 Million USD | 29.24% |
| 2002 Q3 | 559 Million USD | -10.6% |
| 2002 FY | - USD | 1.5% |
| 2001 Q3 | 497 Million USD | 10.22% |
| 2001 Q2 | 459 Million USD | 5.14% |
| 2001 FY | - USD | 25.8% |
| 2001 Q1 | 421 Million USD | 6.47% |
| 2001 Q4 | 557 Million USD | 105.65% |
| 2000 Q2 | 398 Million USD | 75.65% |
| 2000 Q4 | 448 Million USD | -8.01% |
| 2000 FY | - USD | 26.61% |
| 2000 Q3 | 446 Million USD | -35.55% |
| 2000 Q1 | 381 Million USD | -6.31% |
| 1999 FY | - USD | -23.08% |
| 1999 Q1 | 338 Million USD | -5.5% |
| 1999 Q2 | 413 Million USD | -1.77% |
| 1999 Q3 | 350 Million USD | -8.76% |
| 1999 Q4 | 421 Million USD | 16.38% |
| 1998 Q1 | 364 Million USD | 0.84% |
| 1998 FY | - USD | 13.47% |
| 1998 Q4 | 428 Million USD | -36.28% |
| 1998 Q2 | 365 Million USD | 44.44% |
| 1998 Q3 | 276 Million USD | 26.15% |
| 1997 Q4 | 369 Million USD | 13.33% |
| 1997 FY | - USD | 42.67% |
| 1997 Q1 | 347 Million USD | 95.79% |
| 1997 Q2 | 354 Million USD | -49.35% |
| 1997 Q3 | 333 Million USD | -10.76% |
| 1996 Q4 | 347 Million USD | 19.87% |
| 1996 Q3 | 310 Million USD | 6.07% |
| 1996 Q2 | 306 Million USD | 2.19% |
| 1996 Q1 | 296 Million USD | 136.21% |
| 1996 FY | - USD | -4.21% |
| 1995 Q2 | 403 Million USD | 4.1% |
| 1995 Q1 | 381 Million USD | -10.96% |
| 1995 FY | - USD | -20.05% |
| 1995 Q4 | -8 Million USD | -66.67% |
| 1995 Q3 | 374 Million USD | -14.29% |
| 1994 Q4 | 429 Million USD | 13.77% |
| 1994 Q2 | 381 Million USD | 10.34% |
| 1994 Q3 | 385 Million USD | -2.53% |
| 1994 FY | - USD | 45.93% |
| 1994 Q1 | 352 Million USD | 1067.57% |
| 1993 Q3 | 360 Million USD | 20.0% |
| 1993 Q2 | 326 Million USD | -31.61% |
| 1993 Q4 | -288 Million USD | -110.11% |
| 1993 FY | - USD | -31.34% |
| 1993 Q1 | 335 Million USD | 0.9% |
| 1992 Q4 | 413 Million USD | 8.6% |
| 1992 Q1 | 360 Million USD | -15.42% |
| 1992 FY | - USD | -0.19% |
| 1992 Q3 | 387 Million USD | 6.82% |
| 1992 Q2 | 360 Million USD | 2.14% |
| 1991 Q1 | 326 Million USD | 1.47% |
| 1991 Q2 | 375 Million USD | 13.04% |
| 1991 Q3 | 388 Million USD | 2.56% |
| 1991 Q4 | 426 Million USD | 10.25% |
| 1991 FY | - USD | 112.11% |
| 1990 Q4 | 370 Million USD | -1.45% |
| 1990 Q3 | 352 Million USD | -3.63% |
| 1990 Q1 | -312 Million USD | -179.37% |
| 1990 Q2 | 335 Million USD | 219.33% |
| 1990 FY | - USD | -33.36% |
| 1989 Q1 | 267 Million USD | 105.38% |
| 1989 Q3 | 290 Million USD | 25.89% |
| 1989 Q2 | 280 Million USD | -3.03% |
| 1989 Q4 | 365 Million USD | 34.04% |
| 1989 FY | - USD | 4.69% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 2796.586% |
| Accuray Incorporated | 9 Million USD | -30713.631% |
| Align Technology, Inc. | 799.03 Million USD | -247.417% |
| Elevance Health Inc. | 10.49 Billion USD | 73.537% |
| AxoGen, Inc. | -13.32 Million USD | 20928.331% |
| Boston Scientific Corporation | 3.61 Billion USD | 23.166% |
| CVS Health Corporation | 18.17 Billion USD | 84.729% |
| Cardinal Health, Inc. | 1.97 Billion USD | -40.344% |
| Centene Corporation | -463 Million USD | 699.568% |
| DaVita Inc. | 2.34 Billion USD | -18.307% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 78.178% |
| Hologic, Inc. | 1.29 Billion USD | -114.164% |
| Humana Inc. | -561 Million USD | 594.831% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -127.977% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -105.721% |
| Masimo Corporation | 236.7 Million USD | -1072.793% |
| McKesson Corporation | 4.66 Billion USD | 40.519% |
| Patterson Companies, Inc. | 374.75 Million USD | -640.749% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -60.277% |
| ResMed Inc. | 1.6 Billion USD | -73.464% |
| Henry Schein, Inc. | 943 Million USD | -194.38% |
| Teladoc Health, Inc. | 153.99 Million USD | -1702.633% |
| Universal Health Services, Inc. | 1.74 Billion USD | -59.227% |
| Veeva Systems Inc. | 429.33 Million USD | -546.583% |
| Becton, Dickinson and Company | 4.27 Billion USD | 35.064% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -15.952% |
| Danaher Corporation | 7.49 Billion USD | 62.982% |
| Stryker Corporation | 5.16 Billion USD | 46.202% |
| Medtronic plc | 9.05 Billion USD | 69.346% |